Pharmacodynamic efficacy of two different administration routes of SLITonePLUS Birch after 4, 8, 12, 24, 36 weeks of treatment [clinicaltrials_resource:5aac8e2994eb8857c509d0403b6f3634]

Pharmacodynamic efficacy of two different administration routes of SLITonePLUS Birch after 4, 8, 12, 24, 36 weeks of treatment [clinicaltrials_resource:5aac8e2994eb8857c509d0403b6f3634]

specific antibody determination
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:5aac8e2994eb8857c509d0403b6f3634
Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch [clinicaltrials:NCT01191359]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Pharmacodynamic efficacy of two different administration routes of SLITonePLUS Birch after 4, 8, 12, 24, 36 weeks of treatment [clinicaltrials_resource:5aac8e2994eb8857c509d0403b6f3634]

specific antibody determination
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:5aac8e2994eb8857c509d0403b6f3634
Bio2RDF identifier
5aac8e2994eb8857c509d0403b6f3634
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5aac8e2994eb8857c509d0403b6f3634
measure [clinicaltrials_vocabulary:measure]
Pharmacodynamic efficacy of two different administration routes of SLITonePLUS Birch
time frame [clinicaltrials_vocabulary:time-frame]
after 4, 8, 12, 24, 36 weeks of treatment
description
specific antibody determination
identifier
clinicaltrials_resource:5aac8e2994eb8857c509d0403b6f3634
title
Pharmacodynamic efficacy of tw ...... 12, 24, 36 weeks of treatment
@en
inDataset
type
label
Pharmacodynamic efficacy of tw ...... c8e2994eb8857c509d0403b6f3634]
@en